GLP-1 analog peptides (Peptron)

N/A

Report date: 2026/05/12 20:00:17

Base Information

Drug NameGLP-1 analog peptides (Peptron)
Drug Alias Nameglucagon-like peptide-1 analog peptides (Peptron)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPeptron Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPeptron Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A